Voices
Hidehito Horinouchi: Segmentectomy vs Lobectomy in Lung Cancer with Invasive Features
Hidehito Horinouchi/X

Hidehito Horinouchi: Segmentectomy vs Lobectomy in Lung Cancer with Invasive Features

Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:

“JCOG0802/WJOG4607L: Segmentectomy versus Lobectomy in patients with pathologically invasive features.

Segmentx: OS HR 0.657 (CI 0.401-1.077), local relapse HR 2.23 (CI 1.334–3.741).”

Title: Segmentectomy versus lobectomy in non-small-cell lung cancer with pathologically invasive features: a post-hoc supplementary analysis of a multicenter, Phase 3 trial JCOG0802/WJOG4607L

Authors: Shinya Katsumata, Atsushi Kamigaichi, Takaki Akamine, Mitsuhiro Isaka, Masashi Wakabayashi, Noriko Mitome, Masaya Yotsukura, Takahiro Mimae, Aritoshi Hattori, Tomohiro Miyoshi, Makoto Endo, Kazuo Nakagawa, Hiroshige Yoshioka, Yasuhiro Tsutani, Tetsuya Isaka, Tomohiro Maniwa, Yoshihisa Shimada, Ryu Nakajima, Kenji Suzuki, Keiju Aokage, Hisashi Saji, Masahiro Tsuboi, Morihito Okada, Hisao Asamura, Yuta Sekino, Kenichi Nakamura, Haruhiko Fukuda, Shun-ichi Watanabe

Read the article

Hidehito Horinouchi

Other articles featuring Hidehito Horinouchi on OncoDaily.

Aritoshi Hattori Atsushi Kamigaichi cancer Haruhiko Fukuda Hidehito Horinouchi Hiroshige Yoshioka Hisao Asamura Hisashi Saji JCOG JTO & JTO CRR Kazuo Nakagawa Keiju Aokage Kenichi Nakamura Kenji Suzuki LARVOL Lung cancer Makoto Endo Masahiro Tsuboi Masashi Wakabayashi Masaya Yotsukura Mitsuhiro Isaka Morihito Okada Noriko Mitome OncoDaily Oncology Ryu Nakajima Shinya Katsumata Shun-ichi Watanabe Takahiro Mimae Takaki Akamine Tetsuya Isaka Tomohiro Maniwa Tomohiro Miyoshi Yasuhiro Tsutani Yoshihisa Shimada Yuta Sekino